Malignant T-cell-amplified sequence 1 · SINGLE PROTEIN · Homo sapiens
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-15Protein identity stays anchored to UniProt Q9ULC4. Use UniProt Q9ULC4 as the stable identity anchor, then attach disease evidence before program review.
Use UniProt Q9ULC4 as the stable identity anchor, then attach disease evidence before program review.
Malignant T-cell-amplified sequence 1
Review this target as Malignant T-cell-amplified sequence 1, mapped to UniProt Q9ULC4. Sequence length is 181 aa.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Malignant T-cell-amplified sequence 1 as ChEMBL target CHEMBL5724622, mapped to UniProt Q9ULC4. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Malignant T-cell-amplified sequence 1 is the right protein anchor across sources, using UniProt Q9ULC4 as the stable mapping.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Malignant T-cell-amplified sequence 1 |
| Target Type | SINGLE PROTEIN |
| Organism | Homo sapiens |
| UniProt | Q9ULC4 |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Malignant T-cell-amplified sequence 1 |
| UniProt Accession | Q9ULC4 |
| Component Type | Protein |
| Sequence Length | 181 aa |
Malignant T-cell-amplified sequence 1
Review this target as Malignant T-cell-amplified sequence 1, mapped to UniProt Q9ULC4. Sequence length is 181 aa.
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL5981118 | 7.26 | IC50 | 54.5 | Preclinical |
| CHEMBL5874865 | 7.0 | IC50 | 100.0 | Preclinical |
| CHEMBL6018589 | 7.0 | IC50 | 100.0 | Preclinical |
| CHEMBL5898165 | 6.69 | IC50 | 204.0 | Preclinical |
| CHEMBL5904074 | 6.69 | IC50 | 204.0 | Preclinical |
| CHEMBL5883085 | 6.52 | IC50 | 303.0 | Preclinical |
| CHEMBL6031816 | 6.52 | IC50 | 302.0 | Preclinical |
| CHEMBL6052282 | 6.52 | IC50 | 303.0 | Preclinical |
| CHEMBL5918774 | 6.4 | IC50 | 400.0 | Preclinical |
| CHEMBL5764687 | 6.39 | IC50 | 404.0 | Preclinical |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| single protein format | 6 | 1 | 5.0 |
| assay format | 1 | 81 | 4.8 |